Skip to Main Content

Author Details

Yuliang Wang
The Chinese University of Hong Kong
2014
22
14
PMIDPaper TitleJournal TitlePublished Year
36681849Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer.J Transl Med2023
36034466A novel ferroptosis-related gene prognostic index for prognosis and response to immunotherapy in patients with prostate cancer.Front Endocrinol (Lausanne)2022
35526071Endothelial nitric oxide synthase (eNOS)-NO signaling axis functions to promote the growth of prostate cancer stem-like cells.Stem Cell Res Ther2022
33121737Interplay between orphan nuclear receptors and androgen receptor-dependent or-independent growth signalings in prostate cancer.Mol Aspects Med2021
33750894Orphan nuclear receptors as regulators of intratumoral androgen biosynthesis in castration-resistant prostate cancer.Oncogene2021
32226548Nuclear receptor ERRα contributes to castration-resistant growth of prostate cancer via its regulation of intratumoral androgen biosynthesis.Theranostics2020
35117385Towards understanding androgen receptor-independent prostate cancer: an evolving paradigm.Transl Cancer Res2020
31695151Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence.Oncogene2020
32820251Correction: Nuclear receptor HNF4α performs a tumor suppressor function in prostate cancer via its induction of p21-driven cellular senescence.Oncogene2020
32183880Targeting prostate cancer stem-like cells by an immunotherapeutic platform based on immunogenic peptide-sensitized dendritic cells-cytokine-induced killer cells.Stem Cell Res Ther2020
30670091The suppressive effects of miR-508-5p on the odontogenic differentiation of human dental pulp stem cells by targeting glycoprotein non-metastatic melanomal protein B.Stem Cell Res Ther2019
31114331Chromogranin A is a predictor of prognosis in patients with prostate cancer: a systematic review and meta-analysis.Cancer Manag Res2019
29042395Nuclear receptor profiling in prostatospheroids and castration-resistant prostate cancer.Endocr Relat Cancer2018
30122988LRH-1 drives hepatocellular carcinoma partially through induction of c-myc and cyclin E1, and suppression of p21.Cancer Manag Res2018
30042415Nuclear receptor ERRα and transcription factor ERG form a reciprocal loop in the regulation of TMPRSS2:ERG fusion gene in prostate cancer.Oncogene2018
30257704Development of a novel and economical agar-based non-adherent three-dimensional culture method for enrichment of cancer stem-like cells.Stem Cell Res Ther2018
29555975Orphan nuclear receptor TLX contributes to androgen insensitivity in castration-resistant prostate cancer via its repression of androgen receptor transcription.Oncogene2018
29581250LSD1 activates a lethal prostate cancer gene network independently of its demethylase function.Proc Natl Acad Sci U S A2018
29438990Nuclear Receptor LRH-1 Functions to Promote Castration-Resistant Growth of Prostate Cancer via Its Promotion of Intratumoral Androgen Biosynthesis.Cancer Res2018
28849022Significance of the TMPRSS2:ERG gene fusion in prostate cancer.Mol Med Rep2017
27264242The emerging roles of orphan nuclear receptors in prostate cancer.Biochim Biophys Acta2016
25065497Ion channel TRPM8 promotes hypoxic growth of prostate cancer cells via an O2 -independent and RACK1-mediated mechanism of HIF-1α stabilization.J Pathol2014
  • 1 - 22 of 22

Recommended Authors

Cumming School of Medicine, University of Calgary
Career Start Year 2016
Number of shared co-authors 0
Changhai Hospital, Naval Military Medical University
Career Start Year 2014
Number of shared co-authors 0
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2013
Number of shared co-authors 1
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2012
Number of shared co-authors 0
the Second Hospital, Cheeloo College of Medicine, Shandong University
Career Start Year 2011
Number of shared co-authors 0
Center for Genomic and Personalized Medicine, Guangxi Medical University
Career Start Year 2011
Number of shared co-authors 0
Chiba University Graduate School of Medicine
Career Start Year 2011
Number of shared co-authors 0
Cedars-Sinai Medical Center
Career Start Year 2008
Number of shared co-authors 0
School of Pharmacy, University of Wisconsin-Madison
Career Start Year 2008
Number of shared co-authors 1
University of British Columbia
Career Start Year 2008
Number of shared co-authors 2
Icahn School of Medicine at Mount Sinai
Career Start Year 2007
Number of shared co-authors 0
Shanghai Changzheng Hospital
Career Start Year 2007
Number of shared co-authors 0
Center for Personalized Cancer Therapy, University of Massachusetts Boston
Career Start Year 2006
Number of shared co-authors 0
Biomedicine Discovery Institute, Monash University
Career Start Year 2005
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 2005
Number of shared co-authors 3
Agricultural Genomics Institute at Shenzhen, Chinese Academy of Agricultural Sciences
Career Start Year 2005
Number of shared co-authors 1
University of British Columbia
Career Start Year 2004
Number of shared co-authors 1
University of British Columbia
Career Start Year 2002
Number of shared co-authors 1
University of Calgary Cumming School of Medicine, Rockyview General Hospital
Career Start Year 2002
Number of shared co-authors 0
Adelaide Medical School, University of Adelaide
Career Start Year 2002
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 2001
Number of shared co-authors 11
University of Alabama at Birmingham, USA O'Neal Comprehensive Cancer Center
Career Start Year 2001
Number of shared co-authors 1
Changhai Hospital
Career Start Year 2001
Number of shared co-authors 0
University of British Columbia
Career Start Year 2000
Number of shared co-authors 8
Duke University School of Medicine
Career Start Year 2000
Number of shared co-authors 4
University of British Columbia
Career Start Year 2000
Number of shared co-authors 3
Queen's University Belfast
Career Start Year 1997
Number of shared co-authors 0
Fred Hutchinson Cancer Center
Career Start Year 1993
Number of shared co-authors 12
Erasmus University Medical Center
Career Start Year 1990
Number of shared co-authors 1
University of British Columbia
Career Start Year 1987
Number of shared co-authors 10

Collaborators

UF Health Cancer Center
Co-authored papers 1
Kaiser Permanente Northern California, University of California san francisco
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Oregon Health Sciences University
Co-authored papers 1
OHSU Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Center for Health Research, Kaiser Permanente Northwest Research Center
Co-authored papers 1
Knight Cancer Institute and.
Co-authored papers 1
Huntsman Cancer Institute, University of Utah
Co-authored papers 1
Oregon Health & Science University, University of California Berkeley
Co-authored papers 1
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Brody School of Medicine, East Carolina University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University
Co-authored papers 1
Nanoori Gangnam Hospital
Co-authored papers 1
Lombardi Comprehensive Cancer Center, Georgetown University
Co-authored papers 1
Southern California Permanente Medical Group
Co-authored papers 1
Georgetown University
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Co-authored papers 1
12286Rutgers - New Jersey Medical School
Co-authored papers 1
Knight Cancer Institute, Oregon Health & Science University (OHSU)
Co-authored papers 1
Oregon National Primate Research Center
Co-authored papers 1
Rogel Cancer Center, University of Michigan ann arbor
Co-authored papers 1